These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9289430)

  • 21. [A comparative study of the effect of Zoladex treatment versus orchiectomy in patients with advanced prostatic cancer].
    Tsvetkov M; Kumanov Kh; Milkov V; Mladenov D; Neĭkov K
    Khirurgiia (Sofiia); 1996; 49(1):5-8. PubMed ID: 8975090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is 6 months of androgen suppression therapy plus radiotherapy of benefit in patients with localized prostate cancer?
    Pollack A; Horwitz EM
    Nat Clin Pract Oncol; 2005 Jan; 2(1):12-3. PubMed ID: 16264846
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of pelvic endometriosis with goserelin acetate or nafarelin acetate. Comparative study].
    Calvo Lugo GE; Sauceda González LF; Jiménez Perea ML; Díaz Arias FJ
    Ginecol Obstet Mex; 2000 Jan; 68():7-14. PubMed ID: 10774095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer.
    Sverrisdottir A; Johansson H; Johansson U; Bergh J; Rotstein S; Rutqvist L; Fornander T
    Breast Cancer Res Treat; 2011 Aug; 128(3):755-63. PubMed ID: 21625929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of prostate cancer with goserelin and radiotherapy.
    Vicini FA; Kini VR; Martinez AA
    N Engl J Med; 1997 Dec; 337(23):1693-4. PubMed ID: 9411236
    [No Abstract]   [Full Text] [Related]  

  • 26. Primary hormonal treatment in localized and locally advanced prostate cancer: effectiveness and survival predictive factors.
    Utomo NB; Mochtar CA; Umbas R
    Acta Med Indones; 2012 Jan; 44(1):10-5. PubMed ID: 22451179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Encouraging response of an advanced steroid-cell tumor to GnRH agonist therapy.
    Brewer CA; Shevlin D
    Obstet Gynecol; 1998 Oct; 92(4 Pt 2):661-3. PubMed ID: 9764654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cyclophosphamide, methotrexate, and fluorouracil versus tamoxifen plus ovarian suppression as adjuvant treatment of estrogen receptor-positive pre-/perimenopausal breast cancer patients: results of the Italian Breast Cancer Adjuvant Study Group 02 randomized trial. boccardo@hp380.ist.unige.it.
    Boccardo F; Rubagotti A; Amoroso D; Mesiti M; Romeo D; Sismondi P; Giai M; Genta F; Pacini P; Distante V; Bolognesi A; Aldrighetti D; Farris A
    J Clin Oncol; 2000 Jul; 18(14):2718-27. PubMed ID: 10894871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adjuvant therapy during the administration of GnRH agonists].
    Nikolov A; Kolarov G
    Akush Ginekol (Sofiia); 2002; 41(2):36-40. PubMed ID: 12066551
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effectiveness of LH-RH agonist for bone metastases of breast cancer--report of a case].
    Kudoh S; Kawamura H; Suzuki Y; Matsuzaki M; Nishina M; Tsukamoto M
    Gan To Kagaku Ryoho; 1996 May; 23(6):787-90. PubMed ID: 8645031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission.
    Levine D; Park K; Juretzka M; Esch J; Hensley M; Aghajanian C; Lewin S; Konner J; Derosa F; Spriggs D; Iasonos A; Sabbatini P
    Cancer; 2007 Dec; 110(11):2448-56. PubMed ID: 17918264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on the effects of gonadotropin-releasing hormone analogues in the inhibition of ovarian cancer transplanted tumors and in the protection of ovarian function after chemotherapy on nude mice].
    Zhang Y; Lu ZY; Yan XH; Wang JJ; Feng WW; Ding JX; Hua Kq
    Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):892-7. PubMed ID: 22333277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and treatment of primary signet-ring cell carcinoma of the prostate.
    Lilleby W; Axcrona K; Alfsen GC; Urnes T; Hole KH
    Acta Oncol; 2007; 46(8):1195-7. PubMed ID: 17851841
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
    Bernhard J; Zahrieh D; Castiglione-Gertsch M; Hürny C; Gelber RD; Forbes JF; Murray E; Collins J; Aebi S; Thürlimann B; Price KN; Goldhirsch A; Coates AS;
    J Clin Oncol; 2007 Jan; 25(3):263-70. PubMed ID: 17159194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Goserelin (Zoladex)--its role in early breast cancer in pre- and perimenopausal women.
    Jonat W
    Br J Cancer; 2001 Nov; 85 Suppl 2(Suppl 2):1-5. PubMed ID: 11900209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carcinoma of the prostate: neoadjuvant hormonotherapy followed by radiotherapy.
    Scalliet P
    Acta Urol Belg; 1996 May; 64(2):63-4. PubMed ID: 8701815
    [No Abstract]   [Full Text] [Related]  

  • 37. Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy.
    Sverrisdóttir A; Fornander T; Jacobsson H; von Schoultz E; Rutqvist LE
    J Clin Oncol; 2004 Sep; 22(18):3694-9. PubMed ID: 15365065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Penile length changes in men treated with androgen suppression plus radiation therapy for local or locally advanced prostate cancer.
    Haliloglu A; Baltaci S; Yaman O
    J Urol; 2007 Jan; 177(1):128-30. PubMed ID: 17162022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modern tendencies in treatment of atypical glandular hyperplasia--our and foreign experience].
    Ivanov S; Kovachev E; Tsonev A; Abbud A
    Akush Ginekol (Sofiia); 2010; 49(2):47-9. PubMed ID: 20734678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of ovarian suppression in the combined treatment of breast cancer patients in premenopause].
    Shchepotin IB; Zotov AS; Liubota RV; Anikus'ko NF; Liubota II
    Vopr Onkol; 2013; 59(3):397-404. PubMed ID: 23909046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.